These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging. Perk LR; Vosjan MJ; Visser GW; Budde M; Jurek P; Kiefer GE; van Dongen GA Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):250-9. PubMed ID: 19763566 [TBL] [Abstract][Full Text] [Related]
4. Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with (89)Zr(4+): comparison with desferrioxamine-B. Ma MT; Meszaros LK; Paterson BM; Berry DJ; Cooper MS; Ma Y; Hider RC; Blower PJ Dalton Trans; 2015 Mar; 44(11):4884-900. PubMed ID: 25351250 [TBL] [Abstract][Full Text] [Related]
5. Radiolabeling human peripheral blood stem cells for positron emission tomography (PET) imaging in young rhesus monkeys. Tarantal AF; Lee CC; Kukis DL; Cherry SR PLoS One; 2013; 8(10):e77148. PubMed ID: 24098579 [TBL] [Abstract][Full Text] [Related]
6. Re-Evaluations of Zr-DFO Complex Coordination Chemistry for the Estimation of Radiochemical Yields and Chelator-to-Antibody Ratios of Imura R; Ida H; Sasaki I; Ishioka NS; Watanabe S Molecules; 2021 Aug; 26(16):. PubMed ID: 34443566 [TBL] [Abstract][Full Text] [Related]
7. Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET. Verel I; Visser GW; Boerman OC; van Eerd JE; Finn R; Boellaard R; Vosjan MJ; Stigter-van Walsum M; Snow GB; van Dongen GA Cancer Biother Radiopharm; 2003 Aug; 18(4):655-61. PubMed ID: 14503961 [TBL] [Abstract][Full Text] [Related]
8. Dias GM; Ramogida CF; Rousseau J; Zacchia NA; Hoehr C; Schaffer P; Lin KS; Bénard F Nucl Med Biol; 2018 Mar; 58():1-7. PubMed ID: 29291493 [TBL] [Abstract][Full Text] [Related]
9. Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours. Knight JC; Mosley MJ; Kersemans V; Dias GM; Allen PD; Smart S; Cornelissen B Nucl Med Biol; 2019 Mar; 70():14-22. PubMed ID: 30825614 [TBL] [Abstract][Full Text] [Related]
15. Light-induced synthesis of protein conjugates and its application in photoradiosynthesis of Guillou A; Earley DF; Patra M; Holland JP Nat Protoc; 2020 Nov; 15(11):3579-3594. PubMed ID: 33028982 [TBL] [Abstract][Full Text] [Related]
16. In Vivo Characterization of Platinum(II)-Based Linker Technology for the Development of Antibody-Drug Conjugates: Taking Advantage of Dual Labeling with Muns JA; Montserrat V; Houthoff HJ; Codée-van der Schilden K; Zwaagstra O; Sijbrandi NJ; Merkul E; van Dongen GAMS J Nucl Med; 2018 Jul; 59(7):1146-1151. PubMed ID: 29496986 [TBL] [Abstract][Full Text] [Related]
17. Jung KH; Park JW; Lee JH; Moon SH; Cho YS; Lee KH J Nucl Med; 2021 May; 62(5):656-664. PubMed ID: 32917780 [TBL] [Abstract][Full Text] [Related]
18. Genetic Code Expansion for Site-Specific Labeling of Antibodies with Radioisotopes. Koehler C; Sauter PF; Klasen B; Waldmann C; Pektor S; Bausbacher N; Lemke EA; Miederer M ACS Chem Biol; 2023 Mar; 18(3):443-448. PubMed ID: 36889678 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of desferal as a bifunctional chelating agent for labeling antibodies with Zr-89. Meijs WE; Herscheid JD; Haisma HJ; Pinedo HM Int J Rad Appl Instrum A; 1992 Dec; 43(12):1443-7. PubMed ID: 1334954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]